BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kostrzewski T, Cornforth T, Snow SA, Ouro-Gnao L, Rowe C, Large EM, Hughes DJ. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(2): 204-215 [PMID: 28127194 DOI: 10.3748/wjg.v23.i2.204]
URL: https://www.wjgnet.com/1007-9327/full/v23/i2/204.htm
Number Citing Articles
1
Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg. Human hepatic 3D spheroids as a model for steatosis and insulin resistanceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32722-6
2
Franck Da-silva, Xavier Boulenc, Hélène Vermet, Pauline Compigne, Sabine Gerbal-Chaloin, Martine Daujat-Chavanieu, Sylvie Klieber, Patrick Poulin. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin BindingJournal of Pharmaceutical Sciences 2018; 107(7): 1957 doi: 10.1016/j.xphs.2018.03.001
3
Abdul M. Oseini, Banumathi K. Cole, Danny Issa, Ryan E. Feaver, Arun J. Sanyal. Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitisHepatology International 2018; 12(1): 6 doi: 10.1007/s12072-017-9838-6
4
Charlotte J. Green, Thomas Marjot, Jeremy W. Tomlinson, Leanne Hodson. Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?Diabetes, Obesity and Metabolism 2019; 21(4): 749 doi: 10.1111/dom.13592
5
Chase P. Monckton, Salman R. Khetani. Drug-Induced Liver ToxicityMethods in Pharmacology and Toxicology 2018; : 213 doi: 10.1007/978-1-4939-7677-5_11
6
Banumathi K. Cole, Ryan E. Feaver, Brian R. Wamhoff, Ajit Dash. Non-alcoholic fatty liver disease (NAFLD) models in drug discoveryExpert Opinion on Drug Discovery 2018; 13(2): 193 doi: 10.1080/17460441.2018.1410135
7
David J Hughes, Tomasz Kostrzewski, Emma L Sceats. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systemsExperimental Biology and Medicine 2017; 242(16): 1593 doi: 10.1177/1535370217708976
8
Joong‐won Jeon, Seung Hwan Lee, Donghyun Kim, Jong Hwan Sung. In vitro hepatic steatosis model based on gut–liver‐on‐a‐chipBiotechnology Progress 2021; 37(3) doi: 10.1002/btpr.3121
9
Yasamin A. Jodat , Min G. Kang, Kiavash Kiaee, Gyeong J. Kim, Angel F.H. Martinez, Aliza Rosenkranz, Hojae Bae , Su R. Shin. Human-Derived Organ-on-a-Chip for Personalized Drug DevelopmentCurrent Pharmaceutical Design 2019; 24(45): 5471 doi: 10.2174/1381612825666190308150055
10
Francois Taute, Antoni Homs-Corbera, Pierre Gaudriault. The challenges and considerations for emerging or future entrepreneurial researchers in microphysiological systemsOpen Research Europe 2021; 1: 38 doi: 10.12688/openreseurope.13335.1
11
Chase P. Monckton, Grace E. Brown, Salman R. Khetani. Latest impact of engineered human liver platforms on drug developmentAPL Bioengineering 2021; 5(3): 031506 doi: 10.1063/5.0051765
12
Christoph Grün, Brigitte Altmann, Eric Gottwald. Advanced 3D Cell Culture Techniques in Micro-Bioreactors, Part I: A Systematic Analysis of the Literature Published between 2000 and 2020Processes 2020; 8(12): 1656 doi: 10.3390/pr8121656
13
M. Yu. Shkurnikov, E. N. Knyazev, K. A. Fomicheva, M. S. Kasatkin, V. V. Arkov, Yu. A. Makarova. Detection of Low-Abundant MicroRNAs with Hybridization MicrochipsBulletin of Experimental Biology and Medicine 2019; 166(6): 788 doi: 10.1007/s10517-019-04441-z
14
Alexandre J. S. Ribeiro, Xinning Yang, Vikram Patel, Rajnikanth Madabushi, David G. Strauss. Liver Microphysiological Systems for Predicting and Evaluating Drug EffectsClinical Pharmacology & Therapeutics 2019; 106(1): 139 doi: 10.1002/cpt.1458
15
Andreas R. Baudy, Monicah A. Otieno, Philip Hewitt, Jinping Gan, Adrian Roth, Douglas Keller, Radhakrishna Sura, Terry R. Van Vleet, William R. Proctor. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industryLab on a Chip 2020; 20(2): 215 doi: 10.1039/C9LC00768G
16
Bhumika Singh, Mohamed Essameldin Abdelgawad, Zulfiqur Ali, Jarrod Bailey, Elisa Budyn, Prospero Civita, Martin J.D. Clift, John T. Connelly, Samuel Constant, Marius Hittinger, Helena Kandarova, Victoria Rosalind Kearns, Tony Kiuru, Tomasz Kostrzewski, Sebastian Kress, Victoria Marsh Durban, Claus-Michael Lehr, Hayley McMillan, Julia Katharina Metz, Vivian Monteban, Dania Movia, Catia Neto, Carla Owen, Lauri Paasonen, Kerri Anne Palmer, Geoffrey John Pilkington, Karen Pilkington, Adriele Prina-Mello, Clive Roper, Jonathan Sheard, Sheree Smith, Janette Ellen Turner, Ipsita Roy, Melissa Anne Tutty, Eirini Velliou, John Malcolm Wilkinson. Towards More Predictive, Physiological and Animal-free In Vitro Models: Advances in Cell and Tissue Culture 2020 Conference ProceedingsAlternatives to Laboratory Animals 2021; : 026119292110250 doi: 10.1177/02611929211025006
17
Yaqing Wang, Hui Wang, Pengwei Deng, Tingting Tao, Haitao Liu, Shuo Wu, Wenwen Chen, Jianhua Qin. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip SystemACS Biomaterials Science & Engineering 2020; 6(10): 5734 doi: 10.1021/acsbiomaterials.0c00682
18
Norman C. Peterson, Prathap Kumar Mahalingaiah, Aaron Fullerton, Matteo Di Piazza. Application of microphysiological systems in biopharmaceutical research and developmentLab on a Chip 2020; 20(4): 697 doi: 10.1039/C9LC00962K
19
Ehsanollah Moradi, Sasan Jalili-Firoozinezhad, Mehran Solati-Hashjin. Microfluidic organ-on-a-chip models of human liver tissueActa Biomaterialia 2020; 116: 67 doi: 10.1016/j.actbio.2020.08.041
20
Albert Gough, Alejandro Soto-Gutierrez, Lawrence Vernetti, Mo R. Ebrahimkhani, Andrew M. Stern, D. Lansing Taylor. Human biomimetic liver microphysiology systems in drug development and precision medicineNature Reviews Gastroenterology & Hepatology 2021; 18(4): 252 doi: 10.1038/s41575-020-00386-1
21
Jana Hundertmark, Frank Tacke. How effective are nonalcoholic fatty liver disease models for drug discovery?Expert Opinion on Drug Discovery 2020; 15(11): 1237 doi: 10.1080/17460441.2020.1776258
22
Tarun Agarwal, Aruja Rustagi, Joyjyoti Das, Tapas Kumar Maiti. PAMAM dendrimer grafted cellulose paper scaffolds as a novel in vitro 3D liver model for drug screening applicationsColloids and Surfaces B: Biointerfaces 2018; 172: 346 doi: 10.1016/j.colsurfb.2018.08.062
23
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluationScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
24
Gregory H. Underhill, Salman R. Khetani. Advances in Engineered Human Liver Platforms for Drug Metabolism StudiesDrug Metabolism and Disposition 2018; 46(11): 1626 doi: 10.1124/dmd.118.083295
25
Clare L. Thompson, Su Fu, Hannah K. Heywood, Martin M. Knight, Stephen D. Thorpe. Mechanical Stimulation: A Crucial Element of Organ-on-Chip ModelsFrontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.602646
26
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
27
A. M. Ortega-Prieto, J. K. Skelton, S. N. Wai, E. Large, M. Lussignol, G. Vizcay-Barrena, D. Hughes, R. A. Fleck, M. Thursz, M. T. Catanese, M. Dorner. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infectionNature Communications 2018; 9(1) doi: 10.1038/s41467-018-02969-8
28
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic SteatohepatitisHepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
29
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
30
Seung Yeon Lee, Jong Hwan Sung. Gut–liver on a chip toward an in vitro model of hepatic steatosisBiotechnology and Bioengineering 2018; 115(11): 2817 doi: 10.1002/bit.26793
31
Peerut Chienwichai, Onrapak Reamtong, Usa Boonyuen, Trairak Pisitkun, Poorichaya Somparn, Prapin Tharnpoophasiam, Suwalee Worakhunpiset, Supachai Topanurak. Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitroProteome Science 2019; 17(1) doi: 10.1186/s12953-019-0149-9
32
Madeline Cooper, Joseph L. Charest, Jonathan Coppeta. Microfluidic Cell Culture Systems2019; : 1 doi: 10.1016/B978-0-12-813671-3.00001-3
33
Sophie Bauer, Charlotte Wennberg Huldt, Kajsa P. Kanebratt, Isabell Durieux, Daniela Gunne, Shalini Andersson, Lorna Ewart, William G. Haynes, Ilka Maschmeyer, Annika Winter, Carina Ämmälä, Uwe Marx, Tommy B. Andersson. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes modelScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14815-w
34
Elise A. Aeby, Patrick M. Misun, Andreas Hierlemann, Olivier Frey. Microfluidic Hydrogel Hanging-Drop Network for Long-Term Culturing of 3D Microtissues and Simultaneous High-Resolution ImagingAdvanced Biosystems 2018; 2(7): 1800054 doi: 10.1002/adbi.201800054
35
María Virumbrales-Muñoz, José M. Ayuso, Max M. Gong, Mouhita Humayun, Megan K. Livingston, Karina M. Lugo-Cintrón, Patrick McMinn, Yasmín R. Álvarez-García, David J. Beebe. Microfluidic lumen-based systems for advancing tubular organ modelingChemical Society Reviews 2020; 49(17): 6402 doi: 10.1039/D0CS00705F
36
Murat Cirit, Cynthia L. Stokes. Maximizing the impact of microphysiological systems with in vitro–in vivo translationLab on a Chip 2018; 18(13): 1831 doi: 10.1039/C8LC00039E
37
Carlemi Calitz, Josias H. Hamman, Stephen J. Fey, Krzysztof Wrzesinski, Chrisna Gouws. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspectiveToxicology Mechanisms and Methods 2018; 28(5): 369 doi: 10.1080/15376516.2017.1422580
38
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer CellsAdvanced Healthcare Materials 2019; 8(24): 1901379 doi: 10.1002/adhm.201901379
39
David A. Kukla, Salman R. Khetani. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative MedicineSeminars in Liver Disease 2021; 41(03): 368 doi: 10.1055/s-0041-1731016
40
Collin D. Edington, Wen Li Kelly Chen, Emily Geishecker, Timothy Kassis, Luis R. Soenksen, Brij M. Bhushan, Duncan Freake, Jared Kirschner, Christian Maass, Nikolaos Tsamandouras, Jorge Valdez, Christi D. Cook, Tom Parent, Stephen Snyder, Jiajie Yu, Emily Suter, Michael Shockley, Jason Velazquez, Jeremy J. Velazquez, Linda Stockdale, Julia P. Papps, Iris Lee, Nicholas Vann, Mario Gamboa, Matthew E. LaBarge, Zhe Zhong, Xin Wang, Laurie A. Boyer, Douglas A. Lauffenburger, Rebecca L. Carrier, Catherine Communal, Steven R. Tannenbaum, Cynthia L. Stokes, David J. Hughes, Gaurav Rohatgi, David L. Trumper, Murat Cirit, Linda G. Griffith. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology StudiesScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22749-0
41
Ozlem Yesil-Celiktas, Shabir Hassan, Amir K. Miri, Sushila Maharjan, Rawan Al-kharboosh, Alfredo Quiñones-Hinojosa, Yu Shrike Zhang. Mimicking Human Pathophysiology in Organ-on-Chip DevicesAdvanced Biosystems 2018; 2(10): 1800109 doi: 10.1002/adbi.201800109
42
Michela Anna Polidoro, Erika Ferrari, Simona Marzorati, Ana Lleo, Marco Rasponi. Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chipLiver International 2021; 41(8): 1744 doi: 10.1111/liv.14942
43
Shabir Hassan, Shikha Sebastian, Sushila Maharjan, Ami Lesha, Anne‐Marie Carpenter, Xiuli Liu, Xin Xie, Carol Livermore, Yu Shrike Zhang, Ali Zarrinpar. Liver‐on‐a‐Chip Models of Fatty Liver DiseaseHepatology 2020; 71(2): 733 doi: 10.1002/hep.31106
44
Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jérémie Gautheron. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical AppraisalJournal of Clinical Medicine 2020; 10(1): 36 doi: 10.3390/jcm10010036
45
Gregory H. Underhill, Salman R. Khetani. Emerging trends in modeling human liver diseasein vitroAPL Bioengineering 2019; 3(4): 040902 doi: 10.1063/1.5119090
46
Fabrice A. Müller, Shana J. Sturla. Human in vitro models of nonalcoholic fatty liver diseaseCurrent Opinion in Toxicology 2019; 16: 9 doi: 10.1016/j.cotox.2019.03.001
47
Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A ReviewMicromachines 2019; 10(10): 676 doi: 10.3390/mi10100676
48
Pippa J. Gunn, Camilla Pramfalk, Val Millar, Thomas Cornfield, Matthew Hutchinson, Elspeth M. Johnson, Shilpa R. Nagarajan, Perla Troncoso‐Rey, Richard F. Mithen, Katherine E. Pinnick, Maria H. Traka, Charlotte J. Green, Leanne Hodson. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosisPhysiological Reports 2020; 8(13) doi: 10.14814/phy2.14482
49
Shengnan Ya, Weiping Ding, Shibo Li, Kun Du, Yuanyuan Zhang, Chengpan Li, Jing Liu, Fenfen Li, Ping Li, Tianzhi Luo, Liqun He, Ao Xu, Dayong Gao, Bensheng Qiu. On-Chip Construction of Liver Lobules with Self-Assembled Perfusable Hepatic Sinusoid NetworksACS Applied Materials & Interfaces 2021; 13(28): 32640 doi: 10.1021/acsami.1c00794
50
Ajit Dash, William R. Proctor. Microfluidic Cell Culture Systems2019; : 159 doi: 10.1016/B978-0-12-813671-3.00006-2
51
Kun Du, Shibo Li, Chengpan Li, Ping Li, Chunguang Miao, Tianzhi Luo, Bensheng Qiu, Weiping Ding. Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supplyActa Biomaterialia 2021;  doi: 10.1016/j.actbio.2021.07.013
52
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
53
Volker M. Lauschke, Reza Z. Shafagh, Delilah F. G. Hendriks, Magnus Ingelman‐Sundberg. 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and ApplicationsBiotechnology Journal 2019; 14(7): 1800347 doi: 10.1002/biot.201800347
54
Ujjal Sarkar, Kodihalli C. Ravindra, Emma Large, Carissa L. Young, Dinelia Rivera-Burgos, Jiajie Yu, Murat Cirit, David J. Hughes, John S. Wishnok, Douglas A. Lauffenburger, Linda G. Griffith, Steven R. Tannenbaum. Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture SystemDrug Metabolism and Disposition 2017; 45(7): 855 doi: 10.1124/dmd.116.074005
55
Michele Vacca, Jack Leslie, Samuel Virtue, Brian Y. H. Lam, Olivier Govaere, Dina Tiniakos, Sophie Snow, Susan Davies, Kasparas Petkevicius, Zhen Tong, Vivian Peirce, Mette Juul Nielsen, Zsuzsanna Ament, Wei Li, Tomasz Kostrzewski, Diana Julie Leeming, Vlad Ratziu, Michael E. D. Allison, Quentin M. Anstee, Julian L. Griffin, Fiona Oakley, Antonio Vidal-Puig. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitisNature Metabolism 2020; 2(6): 514 doi: 10.1038/s42255-020-0214-9
56
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human modelsHormone Molecular Biology and Clinical Investigation 2018; 0(0) doi: 10.1515/hmbci-2018-0038
57
Zahra Koohestani Sini, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohammad Ali Sardar, Sattar Gorgani Firuzjaee. The Effect of Aerobic Continuous Training on Myonectin, Insulin Resistance and Liver Enzymes in Rats with Nonalcoholic Fatty Liver DiseaseAnnals of Applied Sport Science 2020; 8(4): 0 doi: 10.29252/aassjournal.855
58
Kelly Tan, Philip Keegan, Miles Rogers, Mingjian Lu, James R. Gosset, Joe Charest, Shyam Sundhar Bale. A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditionsLab on a Chip 2019; 19(9): 1556 doi: 10.1039/C8LC01262H
59
Jiu Deng, Zongzheng Chen, Xiuli Zhang, Yong Luo, Zhengzhi Wu, Yao Lu, Tingjiao Liu, Weijie Zhao, Bingcheng Lin. A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cellsBiomedical Microdevices 2019; 21(3) doi: 10.1007/s10544-019-0414-9
60
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoidsBiomaterials 2021; 275: 120904 doi: 10.1016/j.biomaterials.2021.120904
61
Jiu Deng, Xiuli Zhang, Zongzheng Chen, Yong Luo, Yao Lu, Tingjiao Liu, Zhengzhi Wu, Yu Jin, Weijie Zhao, Bingcheng Lin. A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interactionBiomicrofluidics 2019; 13(2): 024101 doi: 10.1063/1.5070088
62
Rajagopal N. Aravalli, Clifford J. Steer. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug MetabolismGenes 2020; 11(7): 729 doi: 10.3390/genes11070729
63
Cliff Rowe, Mohsen Shaeri, Emma Large, Terri Cornforth, Angela Robinson, Tomasz Kostrzewski, Rowena Sison-Young, Christopher Goldring, Kevin Park, David Hughes. Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxinsToxicology in Vitro 2018; 46: 29 doi: 10.1016/j.tiv.2017.09.012